http://jcps.bjmu.edu.cn

• 【研究论文】 • 上一篇    下一篇

苯甲酰胺类Kv1.5钾离子通道阻滞剂的研究

郭小可, 沈征, 于鹏, 褚红喜, 汤依群, 尤启冬*   

  1. 1. 中国药科大学 药物化学教研室, 江苏 南京 210009
    2. 中国药科大学 药理学教研室, 江苏 南京 210009
  • 收稿日期:2012-06-14 修回日期:2012-08-20 出版日期:2012-10-25 发布日期:2012-10-25
  • 通讯作者: 尤启冬*

Discovery of benzamide derivatives as potent Kv1.5 inhibitors

Xiaoke Guo, Zheng Shen, Peng Yu, Hongxi Chu, Yiqun Tang, Qidong You*   

  1. 1. Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China
    2. Research Division of Pharmacology, China Pharmaceutical University, Nanjing 210009, China
  • Received:2012-06-14 Revised:2012-08-20 Online:2012-10-25 Published:2012-10-25
  • Contact: Qidong You*

摘要:

文献报道Kv1.5钾离子通道为治疗心房颤动的一个安全有效的靶点。在前期研究中我们证明化合物CPUY11018有中等的抑制Kv1.5钾离子通道的作用, 但其稳定性较差。为了改善其稳定性同时为了探讨构效关系, 本文利用骨架迁越原理, 合成了4个系列共17个苯甲酰胺类衍生物并测定其Kv1.5阻滞活性。其中, 化合物8c显示出良好的Kv1.5阻滞活性。

关键词: Kv1.5, 超速延迟整流钾离子通道, 钾离子通道, 心房颤动

Abstract: Kv1.5 potassium channel is reported as a potent and safe target for atrial fibrillation. CPUY11018 was proved it had moderate inhibition of Kv1.5. In order to improve the stability of CPUY11018, and investigate the structure-activity relationship, 4 series of benzamide derivatives were synthesized and evaluated. Among them, 8c is a most potent inhibitor of Kv1.5.

Key words: Kv1.5, Ultra-rapid potassium current, Potassium channel, Atrial fibrillation

中图分类号: 

Supporting:

Foundation items: National High-tech R&D Program of China (863 Program, Grant No. 2007AA02Z307), National Major Science and Technology Project of China (Grant No. 2009ZX09103-088 and 2009ZX09501-003).
*Corresponding author. Tel.: 86-25-83271351